# Chemed (CHE) — Analyst Forecast

CHE · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/che/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 2 | 3 | 1 | 6 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $548.00 | $596.00 | $650.00 | 3 |

Last price $515.44 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 25, 2026 | UBS | Initiated Coverage | Buy | $650.00 |
| Jul 31, 2026 | Oppenheimer | Maintained | Outperform | $590.00 |
| Jul 30, 2026 | RBC Capital | Maintained | Sector Perform | $548.00 |
| Jul 9, 2026 | B of A Securities | Maintained | Neutral | $510.00 |
| Apr 27, 2026 | RBC Capital | Maintained | Sector Perform | $436.00 |
| Feb 27, 2026 | Oppenheimer | Maintained | Outperform | $500.00 |
| Feb 27, 2026 | RBC Capital | Downgraded | Outperform → Sector Perform | $422.00 |
| Jan 22, 2026 | Jefferies | Downgraded | Buy → Hold | $475.00 |
| Nov 10, 2025 | RBC Capital | Maintained | Outperform | $572.00 |
| Sep 10, 2025 | B of A Securities | Maintained | Buy | $595.00 |
| Sep 2, 2025 | Jefferies | Upgraded | Hold → Buy | $550.00 |
| Jul 31, 2025 | Oppenheimer | Maintained | Outperform | $580.00 |
| Jul 31, 2025 | RBC Capital | Maintained | Outperform | $589.00 |
| Jul 25, 2025 | Jefferies | Initiated Coverage | Hold | $500.00 |
| Jun 30, 2025 | B of A Securities | Maintained | Buy | $650.00 |
| Jun 30, 2025 | RBC Capital | Maintained | Outperform | $640.00 |
| Apr 28, 2025 | RBC Capital | Maintained | Outperform | $674.00 |
| Mar 14, 2025 | RBC Capital | Maintained | Outperform | $667.00 |
| Nov 5, 2024 | RBC Capital | Maintained | Outperform | $633.00 |
| May 21, 2024 | RBC Capital | Maintained | Outperform | $697.00 |

## Frequently Asked Questions

### What is the price target for CHE stock?

The average 12-month analyst price target for Chemed (CHE) is $596.00, with a high estimate of $650.00 and a low of $548.00, across 3 analysts.

### Is CHE a buy, sell, or hold?

Analysts covering Chemed currently average a Hold rating: 2 buy, 3 hold and 1 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for CHE?

The average price target of $596.00 implies 15.63% upside from the last price of $515.44.

### What is the latest analyst rating on CHE?

On Sep 25, 2026, UBS initiated coverage of Chemed at Buy with a price target of $650.00.

## Similar Stocks

- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).